Genoil (GNOLF) EPS (Basic) (2020 - 2025)
Historic EPS (Basic) for Genoil (GNOLF) over the last 6 years, with Q3 2025 value amounting to -$0.0.
- Genoil's EPS (Basic) fell 365.44% to -$0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.0, marking a year-over-year decrease of 365.44%. This contributed to the annual value of -$0.0 for FY2024, which is 7059.73% up from last year.
- Per Genoil's latest filing, its EPS (Basic) stood at -$0.0 for Q3 2025, which was down 365.44% from -$0.0 recorded in Q2 2025.
- In the past 5 years, Genoil's EPS (Basic) registered a high of -$0.0 during Q3 2024, and its lowest value of -$0.0 during Q1 2022.
- Moreover, its 5-year median value for EPS (Basic) was -$0.0 (2021), whereas its average is -$0.0.
- Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 47235.63% in 2022, then surged by 9791.47% in 2024.
- Quarter analysis of 5 years shows Genoil's EPS (Basic) stood at -$0.0 in 2021, then plummeted by 134.1% to -$0.0 in 2022, then skyrocketed by 66.18% to -$0.0 in 2023, then grew by 16.51% to -$0.0 in 2024, then surged by 90.63% to -$0.0 in 2025.
- Its EPS (Basic) was -$0.0 in Q3 2025, compared to -$0.0 in Q2 2025 and -$0.0 in Q1 2025.